Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals
Roche, Genentech sign license deal with Kiniksa for vixarelimab
Pharmaceutical Business Review
Thu, 08/4/22 - 10:54 am
Kiniksa Pharmaceuticals
Roche
Genentech
vixarelimab
monoclonal antibodies
Kiniksa inks licensing deal to take a Regeneron castoff into Asian markets
Endpoints
Wed, 02/23/22 - 10:31 am
Kiniksa Pharmaceuticals
Regeneron
Arcalyst
Huadong Medicine
Asia
mavrilimumab
Kiniksa preps BLA as Regeneron drug cruises to a PhIII win — shares soar
Endpoints
Mon, 06/29/20 - 10:07 am
Kiniksa Pharmaceuticals
Regeneron
Arcalyst
pericarditis
clinical trials
Kiniksa Files for Proposed Public $180 Million Proposed Public Offering and Additional Private Placement
CP Wire
Wed, 01/30/19 - 11:43 am
Kiniksa Pharmaceuticals
Kiniksa Files for Proposed Public $180 Million Proposed Public Offering and Additional Private Placement
Tue, 01/29/19 - 01:24 pm
Kiniksa Pharmaceuticals
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined
Xconomy
Thu, 05/24/18 - 11:51 am
biotech
IPOs
Kiniksa Pharmaceuticals
Scholar Rock